Early OxyContin Marketing Linked To Long-Term Spread Of Infectious Diseases Associated With Injection Drug Use, in Health Affairs
key takeaway: "Exposure to initial OxyContin marketing statistically significantly increased fatal synthetic opioid-related overdose rates; incidence of acute hepatitis A, hepatitis B, and hepatitis C; and infective endocarditis-related mortality rates after the 2010 OxyContin reformulation."
Comments